Cargando…
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage: Kinetic profile, relationship to interleukin 6 and infarct size
BACKGROUND: The inflammatory marker long pentraxin 3 (PTX3) has been shown to be a strong predictor of 30-day and one-year mortality after acute myocardial infarction. The aim of this study was to evaluate the kinetic profile of PTX3 and its relationship with interleukin 6 (IL-6), high-sensitive C-r...
Autores principales: | Butt, Noreen, Bache-Mathiesen, LK, Ushakova, A, Nordrehaug, JE, Jensen, SE, Munk, PS, Danchin, N, Dubois-Rande, JL, Hansen, HS, Paganelli, F, Corvoisier, P Le, Firat, H, Erlinge, D, Atar, D, Larsen, AI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549329/ https://www.ncbi.nlm.nih.gov/pubmed/32403934 http://dx.doi.org/10.1177/2048872620923641 |
Ejemplares similares
-
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
por: Engblom, Henrik, et al.
Publicado: (2016) -
Dynamic Changes in Pentraxin-3 and Neprilysin in ST Segment Elevation Myocardial Infarction
por: Befekadu, Rahel, et al.
Publicado: (2022) -
Pentraxin 3 depletion (PTX3 KD) inhibited myocardial fibrosis in heart failure after myocardial infarction
por: Xu, Yufang, et al.
Publicado: (2022) -
Design of clinical cardioprotection trials using CMR: impact of myocardial salvage index and a narrow inclusion window on sample size
por: Engblom, Henrik, et al.
Publicado: (2015) -
Evaluation of Serum Pentraxin-3 Level in Patients with Acute Myocardial Infarction Compared with Control Group
por: Firouzjahi, Alireza, et al.
Publicado: (2021)